|
🐜
|
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel.
22 auth.
H. Döhner,
E. Estey,
D. Grimwade,
S. Amadori,
F. Appelbaum,
T. Büchner,
H. Dombret,
B. Ebert,
P. Fenaux,
R. Larson,
...
R. Levine,
F. Lo‐Coco,
T. Naoe,
D. Niederwieser,
G. Ossenkoppele,
M. Sanz,
J. Sierra,
M. Tallman,
H. Tien,
A. Wei,
B. Löwenberg,
C. Bloomfield
|
12 |
2017 |
12
🐜
|
|
🐜
|
Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia.
32 auth.
H. Kantarjian,
C. Sawyers,
A. Hochhaus,
F. Guilhot,
C. Schiffer,
C. Gambacorti-Passerini,
D. Niederwieser,
D. Resta,
R. Capdeville,
U. Zoellner,
M. Talpaz,
B. Druker,
J. Goldman,
S. O’Brien,
N. Russell,
...
T. Fischer,
O. Ottmann,
P. Cony-Makhoul,
T. Facon,
R. Stone,
Carole B. Miller,
M. Tallman,
R. Brown,
M. Schuster,
T. Loughran,
A. Gratwohl,
F. Mandelli,
G. Saglio,
M. Lazzarino,
D. Russo,
M. Baccarani,
E. Morra
|
11 |
2002 |
11
🐜
|
|
🐜
|
Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients.
15 auth.
H. Kolb,
A. Schattenberg,
J. Goldman,
B. Hertenstein,
N. Jacobsen,
W. Arcese,
P. Ljungman,
A. Ferrant,
L. Verdonck,
D. Niederwieser,
...
F. van Rhee,
J. Mittermueller,
T. D. de Witte,
E. Holler,
H. Ansari
|
10 |
1995 |
10
🐜
|
|
🐜
|
European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013.
32 auth.
M. Baccarani,
M. Deininger,
G. Rosti,
A. Hochhaus,
S. Soverini,
J. Apperley,
F. Cervantes,
R. Clark,
J. Cortes,
F. Guilhot,
H. Hjorth-Hansen,
T. Hughes,
H. Kantarjian,
Dong-Wook Kim,
R. Larson,
...
J. Lipton,
F. Mahon,
G. Martinelli,
J. Mayer,
Martin C. Müller,
D. Niederwieser,
F. Pane,
J. Radich,
P. Rousselot,
G. Saglio,
S. Saussele,
C. Schiffer,
R. Silver,
B. Simonsson,
J. Steegmann,
J. Goldman,
R. Hehlmann
|
10 |
2013 |
10
🐜
|
|
🐜
|
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation
29 auth.
R. Stone,
S. Mandrekar,
B. Sanford,
K. Laumann,
S. Geyer,
C. Bloomfield,
C. Thiede,
T. Prior,
K. Döhner,
G. Marcucci,
F. Lo‐Coco,
R. Klisovic,
A. Wei,
J. Sierra,
M. Sanz,
...
J. Brandwein,
T. D. de Witte,
D. Niederwieser,
F. Appelbaum,
B. Medeiros,
M. Tallman,
J. Krauter,
R. Schlenk,
A. Ganser,
H. Serve,
G. Ehninger,
S. Amadori,
R. Larson,
H. Döhner
|
10 |
2017 |
10
🐜
|
|
🐜
|
Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects.
24 auth.
P. Mcsweeney,
D. Niederwieser,
J. Shizuru,
B. Sandmaier,
A. Molina,
D. Maloney,
T. Chauncey,
T. Gooley,
U. Hegenbart,
R. Nash,
...
J. Radich,
J Wagner,
Steven Minor,
F. Appelbaum,
W. Bensinger,
E. Bryant,
M. Flowers,
G. Georges,
F. Grumet,
H. Kiem,
B. Torok-Storb,
Cong Yu,
K. Blume,
R. Storb
|
10 |
2001 |
10
🐜
|
|
🐜
|
Diagnosis and Management of AML in Adults: 2022 ELN Recommendations from an International Expert Panel.
23 auth.
H. Döhner,
A. Wei,
F. Appelbaum,
C. Craddock,
C. Dinardo,
H. Dombret,
B. Ebert,
P. Fenaux,
L. Godley,
R. Hasserjian,
...
R. Larson,
R. Levine,
Y. Miyazaki,
D. Niederwieser,
G. Ossenkoppele,
C. Röllig,
J. Sierra,
E. Stein,
M. Tallman,
H. Tien,
Jianxiang Wang,
A. Wierzbowska,
B. Löwenberg
|
10 |
2022 |
10
🐜
|
|
🐜
|
Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet.
19 auth.
M. Baccarani,
G. Saglio,
J. Goldman,
A. Hochhaus,
B. Simonsson,
F. Appelbaum,
J. Apperley,
F. Cervantes,
J. Cortes,
M. Deininger,
...
A. Gratwohl,
F. Guilhot,
M. Horowitz,
T. Hughes,
H. Kantarjian,
R. Larson,
D. Niederwieser,
R. Silver,
R. Hehlmann
|
10 |
2006 |
10
🐜
|
|
🐜
|
Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet.
20 auth.
M. Baccarani,
J. Cortes,
F. Pane,
D. Niederwieser,
G. Saglio,
J. Apperley,
F. Cervantes,
M. Deininger,
A. Gratwohl,
F. Guilhot,
...
A. Hochhaus,
M. Horowitz,
T. Hughes,
H. Kantarjian,
R. Larson,
J. Radich,
B. Simonsson,
R. Silver,
J. Goldman,
R. Hehlmann
|
10 |
2009 |
10
🐜
|
|
🐜
|
Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma
10 auth.
C. Huber,
J. R. Batchelor,
D. Fuchs,
A. Hausen,
A. Lang,
D. Niederwieser,
...
G. Reibnegger,
P. Swetly,
J. Troppmair,
H. Wachter
|
10 |
1984 |
10
🐜
|
|
🐜
|
European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia
34 auth.
A. Hochhaus,
M. Baccarani,
R. Silver,
C. Schiffer,
J. Apperley,
F. Cervantes,
R. Clark,
J. Cortes,
M. Deininger,
F. Guilhot,
H. Hjorth-Hansen,
T. Hughes,
J. Janssen,
H. Kantarjian,
Dong-Kee Kim,
...
R. Larson,
J. Lipton,
F. Mahon,
J. Mayer,
F. Nicolini,
D. Niederwieser,
F. Pane,
J. Radich,
D. Réa,
J. Richter,
G. Rosti,
P. Rousselot,
G. Saglio,
Susanne Saussele,
S. Soverini,
J. Steegmann,
A. Turkina,
A. Zaritskey,
Ruediger Hehlmann
|
10 |
2020 |
10
🐜
|
|
🐜
|
Hematopoietic stem cell transplantation: a global perspective.
14 auth.
A. Gratwohl,
H. Baldomero,
M. Aljurf,
M. Pasquini,
L. Bouzas,
A. Yoshimi,
J. Szer,
J. Lipton,
A. Schwendener,
M. Gratwohl,
...
K. Frauendorfer,
D. Niederwieser,
M. Horowitz,
Y. Kodera
|
9 |
2010 |
9
🐜
|
|
🐜
|
Dasatinib induces notable hematologic and cytogenetic responses in chronic-phase chronic myeloid leukemia after failure of imatinib therapy.
17 auth.
A. Hochhaus,
H. Kantarjian,
M. Baccarani,
J. Lipton,
J. Apperley,
B. Druker,
T. Facon,
S. Goldberg,
F. Cervantes,
D. Niederwieser,
...
R. Silver,
R. Stone,
T. Hughes,
Martin C Muller,
R. Ezzeddine,
A. Countouriotis,
N. Shah
|
9 |
2007 |
9
🐜
|
|
🐜
|
Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability.
8 auth.
N. Romani,
D. Reider,
M. Heuer,
S. Ebner,
E. Kämpgen,
B. Eibl,
...
D. Niederwieser,
G. Schuler
|
9 |
1996 |
9
🐜
|
